Impact of Milk and Yogurt Supplementation on Bone Health, Body Composition, and Gut Microbiota in Canadian Young Adults
NCT ID: NCT06265246
Last Updated: 2024-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
99 participants
INTERVENTIONAL
2024-09-01
2028-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Increased Greek Yogurt Consumption in Youth and Young Adult Athletes
NCT05922462
Bone and Inflammatory Outcomes - Nutrition and Exercise Trials
NCT06041087
The Effects of Milk Protein Versus Soy Protein on Essential Omega-3 Fatty Acid Metabolism
NCT05820256
Milk Supplementation and Energy Balance.
NCT00729170
The Effect of Dairy Intake on Body Weight and Composition and Metabolic Health in Adolescents and Seniors
NCT06879652
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The specific objectives of the research are:
1. To examine the effects of milk and yogurt supplementation on bone mineral density (BMD), bone mineral content (BMC), bone structure, and bone geometry of Canadian adults aged 19-30 years.
2. To examine the effects of milk and yogurt supplementation on hormonal indices (parathyroid hormone, Insulin-like growth factor 1, 25-hydroxyvitamin D) related to bone metabolism in Canadian adults aged 19 to 30.
3. To examine the effects of milk and yogurt supplementation on biochemical indices of bone turnover (Procollagen type 1 N-propeptide, Osteocalcin, Bone alkaline phosphatase, N-terminal telopeptide of type I collagen, C-terminal telopeptide of type 1 collagen) in Canadian adults aged 19-30.
4. To examine the effects of milk and fermented milk product supplementation on body composition (bone-free lean tissue mass, total body fat mass, abdominal fat mass, percent total body fat) of Canadian adults aged 19 to 30.
5. To examine the effects of milk and fermented milk product supplementation on gut microbiota of Canadian adults aged 19 to 30
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
1. Habitual diet (control) (n=33)
2. Habitual diet + 1.5 servings of milk providing approx. 500 mg Ca/day (either 1% fat milk, or 2% fat milk) (n=33)
3. Habitual diet + 2 servings of yogurt providing approx. 500 mg Ca/day (either 1% fat plain yogurt, 2% fat plain yogurt, 1% fat flavoured yogurt, 2% fat flavoured yogurt) (n=33)
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Habitual Diet (Control)
33 participants in this arm will continue to take their usual diet without any intervention.
No interventions assigned to this group
Habitual Diet + 1.5 Servings of Milk
Habitual Diet + Milk
1.5 servings of milk \[providing approx. 500 mg Ca/day\] per day (either 1% fat milk, or 2% fat milk)
Habitual Diet + 2 Servings of Yogurt
Habitual Diet + Yogurt
2 servings of yogurt \[providing approx. 500 mg Ca/day\] per day (either 1% fat plain yogurt, 2% fat plain yogurt, 1% fat flavoured yogurt, 2% fat flavoured yogurt)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Habitual Diet + Milk
1.5 servings of milk \[providing approx. 500 mg Ca/day\] per day (either 1% fat milk, or 2% fat milk)
Habitual Diet + Yogurt
2 servings of yogurt \[providing approx. 500 mg Ca/day\] per day (either 1% fat plain yogurt, 2% fat plain yogurt, 1% fat flavoured yogurt, 2% fat flavoured yogurt)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Dietary calcium intake below 1000mg/ day
* living in the Saskatoon area (Saskatchewan, Canada)
Exclusion Criteria
* Total dairy intake of more than 1 serving per day
* Body mass index greater than to 30 kg/m2
* Medical history of metabolic bone, liver, endocrine, connective tissue, and respiratory diseases, thyroid disorders, or cancer
* Diagnosed cases with secondary osteoporosis due to hypoparathyroidism
* Hormonal disorders or disturbances
* Taking medications known to influence bone mass and density (e.g., steroids, diuretics, heparin, and cancer drugs)
* Cow's milk allergy
* Pregnant or lactating women, or those planning to conceive during the duration of the trial
19 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dairy Farmers of Canada
OTHER
Agriculture and Agri-Food Canada
OTHER_GOV
University of Saskatchewan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hassanali Vatanparast
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hassan Vatanparast, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Saskatchewan
Phil Chilibeck, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Saskatchewan
Sandra Clarke
Role: PRINCIPAL_INVESTIGATOR
Agriculture and Agri-Food Canada
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Saskatchewan
Saskatoon, Saskatchewan, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hassan Vatanparast
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
104993
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.